SELLAS Life Sciences Group has signed a definitive agreement to merge with Galena Biopharma.

SELLAS will become a wholly owned subsidiary of Galena, following the completion of the merger.

Go deeper with GlobalData

Data Insights

The gold standard of business intelligence.

Find out more

SELLAS is a clinical-stage biopharmaceutical company based in Bermuda, while Galena Biopharma is a late-stage biopharmaceutical company based in the US.

"Clinical-stage pharmaceutical company Cempra plans to merge with commercial-stage biopharmaceutical company, Melinta Therapeutics."

Clinical-stage pharmaceutical company Cempra plans to merge with commercial-stage biopharmaceutical company, Melinta Therapeutics.

The merged entity will be known as Melinta Therapeutics.

Both companies involved in the merger are based in the US.

GlobalData Strategic Intelligence

US Tariffs are shifting - will you react or anticipate?

Don’t let policy changes catch you off guard. Stay proactive with real-time data and expert analysis.

By GlobalData

Clinical Trials Arena Excellence Awards - Have you nominated?

Nominations are now open for the prestigious Clinical Trials Arena Excellence Awards - one of the industry's most recognised programmes celebrating innovation, leadership, and impact. This is your chance to showcase your achievements, highlight industry advancements, and gain global recognition. Don't miss the opportunity to be honoured among the best - submit your nomination today!

Nominate Now